Partner Michael Leiter and counsel Daniel Gerkin look at the impact of the coronavirus/COVID-19 outbreak on the Committee on Foreign Investment in the United States. Although some delays are possible, CFIUS is maintaining its focus on China-related transactions and will likely increase scrutiny of health and pharmaceutical sector deals.
The Pandemic's Early Effects On Foreign Trade, Investment
Law360